Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Implementing national cancer control plans
Dr Eduardo Cazap and Dr Lisa Stevens
Implementing national cancer control plans ( Dr Eduardo Cazap and Dr Lisa Stevens )
24 Jun 2019
Comment: Chemotherapy for frail and elderly patients with advanced gastroesophag...
Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
Comment: Chemotherapy for frail and elderly patients with advanced gastroesophageal cancer ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )
13 Jun 2019
Ado-trastuzumab emtansine in patients with HER2 amplified salivary gland cancers...
Prof Bob Li - Memorial Sloan Kettering Cancer Center, New York City, USA
Ado-trastuzumab emtansine in patients with HER2 amplified salivary gland cancers: Results from a phase II basket trial ( Prof Bob Li - Memorial Sloan Kettering Cancer Center, New York City, USA )
11 Jun 2019
Principle and technique for radiofrequency ablation of benign thyroid nodules
Prof Kwang Hwi Lee - Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, United A...
Principle and technique for radiofrequency ablation of benign thyroid nodules ( Prof Kwang Hwi Lee - Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, United Arab Emirates )
8 May 2019
Perception of tobacco use in young adults of urban India
Ms Soumita Ghose - Tata Medical Centre, Kolkata, India
Perception of tobacco use in young adults of urban India ( Ms Soumita Ghose - Tata Medical Centre, Kolkata, India )
28 Mar 2019
Updates in head and neck cancers
Prof Jean-Pascal Machiels - University Clinic Saint-Luc, Brussels, Belgium
Updates in head and neck cancers ( Prof Jean-Pascal Machiels - University Clinic Saint-Luc, Brussels, Belgium )
22 Oct 2018
First-line pembrolizumab for recurrent/metastatic head and neck squamous cell ca...
Prof Barbara Burtness - Yale University School of Medicine and Yale Cancer Cente...
First-line pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma ( Prof Barbara Burtness - Yale University School of Medicine and Yale Cancer Center New Haven, USA )
22 Oct 2018
Cisplatin superior to cetuximab for HPV oropharyngeal cancer
Prof Hisham Mehanna - University of Birmingham , Birmingham, UK
Cisplatin superior to cetuximab for HPV oropharyngeal cancer ( Prof Hisham Mehanna - University of Birmingham , Birmingham, UK )
22 Oct 2018
Cisplatin v cetuximab for HPV associated oropharyngeal cancer
Prof Hisham Mehanna - University of Birmingham , Birmingham, UK
Cisplatin v cetuximab for HPV associated oropharyngeal cancer ( Prof Hisham Mehanna - University of Birmingham , Birmingham, UK )
22 Oct 2018
KEYNOTE048: First line pembrolizumab for recurrent or metastatic head and neck s...
Prof Barbara Burtness - Yale Cancer Center, New Haven, USA
KEYNOTE048: First line pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma ( Prof Barbara Burtness - Yale Cancer Center, New Haven, USA )
22 Oct 2018
ESMO 2018: Highlights
Prof Gordon McVie , Will Davies
ESMO 2018: Highlights ( Prof Gordon McVie , Will Davies )
22 Oct 2018
The promise of immunotherapy in head and neck, and prostate cancer
Dr Luis Larrea - NISA, Valencia, Spain
The promise of immunotherapy in head and neck, and prostate cancer ( Dr Luis Larrea - NISA, Valencia, Spain )
7 Aug 2018